S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Aktualne aktualizacje dla Aspen Pharmacare Holdings [APNHY]

Giełda: OTC Sektor: Healthcare Branża: Drug Manufacturers—Specialty & Generic
Ostatnio aktualizowano3 geg. 2024 @ 16:37

7.59% $ 12.49

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 16:37):

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments...

Stats
Dzisiejszy wolumen 109.00
Średni wolumen 190.00
Kapitalizacja rynkowa 5.55B
Last Dividend $0.184 ( 2023-09-21 )
Next Dividend $0 ( N/A )
P/E 21.53
ATR14 $0 (0.00%)

Aspen Pharmacare Holdings Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aspen Pharmacare Holdings Finanse

Annual 2023
Przychody: $2.29B
Zysk brutto: $1.02B (44.59 %)
EPS: $0.660
FY 2023
Przychody: $2.29B
Zysk brutto: $1.02B (44.59 %)
EPS: $0.660
FY 2022
Przychody: $2.54B
Zysk brutto: $1.15B (45.40 %)
EPS: $0.940
FY 2021
Przychody: $37.77B
Zysk brutto: $17.76B (47.03 %)
EPS: $10.53

Financial Reports:

No articles found.

Aspen Pharmacare Holdings Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.133
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0.184
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Aspen Pharmacare Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.17 - Stable (3.39%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.101 2010-10-06
Last Dividend $0.184 2023-09-21
Next Dividend $0 N/A
Payout Date 2023-10-11
Next Payout Date N/A
# dividends 12 --
Total Paid Out $2.03 --
Avg. Dividend % Per Year 0.00% --
Score 2.69 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.17
Div. Directional Score 7.90 --
Next Divdend (Est)
(2024-08-07)
$0.190 Estimate 3.02 %
Dividend Stability
0.24 Very Poor
Dividend Score
2.69
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TTNDF Ex Dividend Knight 2023-08-29 Annually 0 0.00%
IVSBF Ex Dividend Knight 2023-11-03 Annually 0 0.00%
BDORY Ex Dividend Knight 2023-09-12 Bi-Monthly 0 0.00%
RBSFY Ex Dividend Knight 2023-06-09 Annually 0 0.00%
EMSHF Ex Dividend Knight 2023-08-15 Annually 0 0.00%
VWAPY Ex Dividend Junior 2023-05-11 Annually 0 0.00%
KTHN Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
CBCFF Ex Dividend Junior 2024-03-28 Annually 0 0.00%
SEBC Ex Dividend Junior 2023-08-30 Quarterly 0 0.00%
FOTB Ex Dividend Junior 2023-05-31 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1141.5007.7210.00[0 - 0.5]
returnOnAssetsTTM0.03491.2008.8410.00[0 - 0.3]
returnOnEquityTTM0.07431.500-0.285-0.428[0.1 - 1]
payoutRatioTTM0.315-1.0006.85-6.85[0 - 1]
currentRatioTTM1.9180.8005.414.33[1 - 3]
quickRatioTTM1.0530.8008.516.81[0.8 - 2.5]
cashRatioTTM0.5051.5008.3010.00[0.2 - 2]
debtRatioTTM0.259-1.5005.68-8.52[0 - 0.6]
interestCoverageTTM88.181.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM14.112.005.3010.00[0 - 30]
freeCashFlowPerShareTTM7.622.006.1910.00[0 - 20]
debtEquityRatioTTM0.422-1.5008.31-10.00[0 - 2.5]
grossProfitMarginTTM0.4501.0005.835.83[0.2 - 0.8]
operatingProfitMarginTTM0.2001.0008.008.00[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1741.000-0.146-0.146[0.2 - 2]
assetTurnoverTTM0.3070.800-1.290-1.032[0.5 - 2]
Total Score10.62

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM21.091.0007.970[1 - 100]
returnOnEquityTTM0.07432.50-0.183-0.428[0.1 - 1.5]
freeCashFlowPerShareTTM7.622.007.4610.00[0 - 30]
dividendYielPercentageTTM0.004191.5009.900[0 - 0.4]
operatingCashFlowPerShareTTM14.112.005.3010.00[0 - 30]
payoutRatioTTM0.3151.5006.85-6.85[0 - 1]
pegRatioTTM0.03561.500-3.100[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1471.0008.830[0.1 - 0.5]
Total Score5.17

Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej